Assessing asthma severity based on claims data: a systematic review
- PMID: 26931557
- PMCID: PMC5313583
- DOI: 10.1007/s10198-016-0769-2
Assessing asthma severity based on claims data: a systematic review
Abstract
Introduction: Asthma is one of the most common chronic diseases in Germany. Substantial economic evaluation of asthma cost requires knowledge of asthma severity, which is in general not part of claims data. Algorithms need to be defined to use this data source.
Aims and objectives: The aim of this study was to systematically review the international literature to identify algorithms for the stratification of asthma patients according to disease severity based on available information in claims data.
Methods: A systematic literature review was conducted in September 2015 using the DIMDI SmartSearch, a meta search engine including several databases with a national and international scope, e.g. BIOSIS, MEDLINE, and EMBASE. Claims data based studies that categorize asthma patients according to their disease severity were identified.
Results: The systematic research yielded 54 publications assessing asthma severity based on claims data. Thirty-nine studies used a standardized algorithm such as HEDIS, Leidy, the GINA based approach or CACQ. Sixteen publications applied a variety of different criteria for the severity categorisation such as asthma diagnoses, asthma-related drug prescriptions, emergency department visits, and hospitalisations.
Conclusion: There is no best practice method for the categorisation of asthma severity with claims data. Rather, a combination of algorithms seems to be a pragmatic approach. A transfer to the German context is not entirely possible without considering particular conditions associated with German claims data.
Keywords: Asthma; Claims data; Economic evaluation; Exacerbation; GINA; HEDIS; Intermittent; Leidy; Persistent; Systematic review.
Conflict of interest statement
The study was funded by an unrestricted grant from GlaxoSmithKline. Benno Bechtel is an employee of GlaxoSmithKline. Jennifer Scarlet Haas, Christian Jacob and Sebastian Braun are employed by Xcenda GmbH, which received funding for the conduct of the study from GlaxoSmithKline. Peter Kardos received consulting fees for the conduct of the study from Xcenda GmbH.
References
-
- Statistisches Bundesamt. Krankheitskosten in Mio. € für Deutschland (2014). http://www.destatis.de
-
- Bundesärztekammer, Kassenärztliche Bundesvereinigung, & Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale Versorgungsleitlinie Asthma. 2nd edition[Version 5] (2009). http://www.versorgungsleitlinien.de/themen/asthma/pdf/nvl-asthma-2.aufl....
-
- Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Szefler SJ, Sullivan SD, Thomas MD, Wenzel SE, Reddel HK. A new perspective on concepts of asthma severity and control. Eur. Respir. J. 2008;32(3):545–554. doi: 10.1183/09031936.00155307. - DOI - PubMed
-
- Global Initiative for Asthma. Asthma Management and Prevention. National Institutes of Health, Bethesda, NIH Publication number 95-3659A (1995)
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical